Literature DB >> 25673631

Critical Care for the Patient With Multiple Trauma.

Michal Radomski1, Sara Zettervall1, Mary Elizabeth Schroeder1, Jonathan Messing1, James Dunne1, Babak Sarani2.   

Abstract

Trauma remains the leading cause of death worldwide and the leading cause of death in those less than 44 years old in the United States. Admission to a verified trauma center has been shown to decrease mortality following a major injury. This decrease in mortality has been a direct result of improvements in the initial evaluation and resuscitation from injury as well as continued advances in critical care. As such, it is vital that intensive care practitioners be familiar with various types of injuries and their associated treatment strategies as well as their potential complications in order to minimize the morbidity and mortality frequently seen in this patient population.
© The Author(s) 2015.

Entities:  

Keywords:  critical care; injury; trauma

Mesh:

Year:  2015        PMID: 25673631     DOI: 10.1177/0885066615571895

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  3 in total

1.  Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) after Polytrauma: A Rare Syndrome with Major Consequences.

Authors:  Lillian Hesselink; Ruben J Hoepelman; Roy Spijkerman; Mark C H de Groot; Karlijn J P van Wessem; Leo Koenderman; Luke P H Leenen; Falco Hietbrink
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

2.  Predictors of Acute Mortality After Open Pelvic Fracture: Experience From 37 Patients From A Level I Trauma Center.

Authors:  I-Chuan Tseng; I-Jung Chen; Ying-Chao Chou; Yung-Heng Hsu; Yi-Hsun Yu
Journal:  World J Surg       Date:  2020-07-06       Impact factor: 3.352

3.  Prediction of mortality in severely injured patients with facial bone fractures.

Authors:  Ievgen Shumynskyi; Vitaliy Gurianov; Oleksandr Kaniura; Andrey Kopchak
Journal:  Oral Maxillofac Surg       Date:  2021-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.